Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 142425, 11 pages
http://dx.doi.org/10.1155/2014/142425
Review Article

Inflammation-Based Scores: A New Method for Patient-Targeted Strategies and Improved Perioperative Outcome in Cancer Patients

1Department of Anaesthesia and Intensive Care, Foundation IRCCS Policlinico San Matteo, P.le Golgi 19, 27100 Pavia, Italy
2SIMPAR (Study in Multidisciplinary Pain Research) Group, Italy
3Department of Surgical, Medical, Diagnostic and Pediatric Science, University of Pavia, Via Aselli 45, 27100 Pavia, Italy
4Pain Therapy Service, Foundation IRCCS Policlinico San Matteo, P.le Golgi 19, 27100 Pavia, Italy
5Department of Anesthesia and Perioperative Medicine, Catholic University of Louvain, St. Luc Hospital, 10 Avenue Hippocrate, 1200 Brussels, Belgium
6Department of Anesthesia and Intensive Care, University of Parma, Via Gramsci 14, 43126 Parma, Italy

Received 10 December 2013; Revised 10 March 2014; Accepted 19 March 2014; Published 27 April 2014

Academic Editor: Melchiorre Cervello

Copyright © 2014 Dario Bugada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Demaria, E. Pikarsky, M. Karin et al., “Cancer and inflammation: promise for biologic therapy,” Journal of Immunotherapy, vol. 33, no. 4, pp. 335–351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. A. Dinarello, “The paradox of pro-inflammatory cytokines in cancer,” Cancer and Metastasis Reviews, vol. 25, no. 3, pp. 307–313, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Forget, P. Coulie, M. Retsky, R. Demicheli, J.-P. Machiels, and M. de Kock, “Is there a rationale for an anaesthesiologist’s role against cancer recurrence?” Acta Anaesthesiologica Belgica, vol. 64, no. 1, pp. 15–24, 2013. View at Google Scholar
  4. B. Azab, V. R. Bhatt, J. Phookan et al., “Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients,” Annals of Surgical Oncology, vol. 19, no. 1, pp. 217–224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Lee, S. Y. Oh, S. H. Kim et al., “Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy,” BMC Cancer, vol. 13, article 350, 2013. View at Publisher · View at Google Scholar
  6. W. He, C. Yin, G. Guo et al., “Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer,” Medical Oncology, vol. 30, no. 1, article 439, 2013. View at Publisher · View at Google Scholar
  7. J. F. Feng, Y. Huang, Q. Zhao, and Q. X. Chen, “Clinical significance of preoperative neutrophil lymphocyte ratio versus platelet lymphocyte ratio in patients with small cell carcinoma of the esophagus,” The Scientific World Journal, vol. 2013, Article ID 504365, 7 pages, 2013. View at Publisher · View at Google Scholar
  8. M. Stotz, A. Gerger, F. Eisner et al., “Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer,” British Journal of Cancer, vol. 109, no. 2, pp. 416–421, 2013. View at Publisher · View at Google Scholar
  9. G. Absenger, J. Szkandera, M. Stotz et al., “Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer,” Anticancer Research, vol. 33, no. 10, pp. 4591–4594, 2013. View at Google Scholar
  10. D. Gomez, S. Farid, H. Z. Malik et al., “Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma,” World Journal of Surgery, vol. 32, no. 8, pp. 1757–1762, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Cho, H. W. Hur, S. W. Kim et al., “Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment,” Cancer Immunology, Immunotherapy, vol. 58, no. 1, pp. 15–23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. C. H. Kao, N. Pavlakis, R. Harvie et al., “High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy,” Clinical Cancer Research, vol. 16, no. 23, pp. 5805–5813, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Jung, Y. K. Park, O. Jeong et al., “Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer,” Journal of Surgical Oncology, vol. 104, no. 5, pp. 504–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Y. Kim, T. Park, S. H. Jeong et al., “Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas,” Endocrine, 2013. View at Publisher · View at Google Scholar
  15. S. R. Walsh, E. J. Cook, F. Goulder, T. A. Justin, and N. J. Keeling, “Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer,” Journal of Surgical Oncology, vol. 91, no. 3, pp. 181–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. H.-Y. Hung, J.-S. Chen, C. Y. Yeh et al., “Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy,” International Journal of Colorectal Disease, vol. 26, no. 8, pp. 1059–1065, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. K. J. Halazun, A. Aldoori, H. Z. Malik et al., “Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases,” European Journal of Surgical Oncology, vol. 34, no. 1, pp. 55–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Tomita, T. Shimizu, T. Ayabe, A. Yonei, and T. Onitsuka, “Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer,” Anticancer Research, vol. 31, no. 9, pp. 2995–2998, 2011. View at Google Scholar · View at Scopus
  19. D. Keizman, M. Ish-Shalom, P. Huang et al., “The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma,” European Journal of Cancer, vol. 48, no. 2, pp. 202–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. H. S. Kim, K. H. Han, H. H. Chung et al., “Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison,” European Journal of Surgical Oncology, vol. 36, no. 7, pp. 691–698, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Z. Sharaiha, K. J. Halazun, F. Mirza et al., “Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer,” Annals of Surgical Oncology, vol. 18, no. 12, pp. 3362–3369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Garcea, N. Ladwa, C. P. Neal, M. S. Metcalfe, A. R. Dennison, and D. P. Berry, “Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma,” World Journal of Surgery, vol. 35, no. 4, pp. 868–872, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Forget, J. P. Machiels, P. G. Coulie et al., “Neutrophil: lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery,” Annals of Surgical Oncology, vol. 20, supplement 3, pp. S650–S660, 2013. View at Publisher · View at Google Scholar
  24. S. L. Ong, G. Garcea, S. C. Thomasset et al., “Surrogate markers of resectability in patients undergoing exploration of potentially resectable pancreatic adenocarcinoma,” Journal of Gastrointestinal Surgery, vol. 12, no. 6, pp. 1068–1073, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Aliustaoglu, A. Bilici, M. Seker et al., “The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer,” Hepato-Gastroenterology, vol. 57, no. 99-100, pp. 640–645, 2010. View at Google Scholar · View at Scopus
  26. M. Aliustaoglu, A. Bilici, B. B. O. Ustaalioglu et al., “The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment,” Medical Oncology, vol. 27, no. 4, pp. 1060–1065, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. X. An, P.-R. Ding, Y.-H. Li et al., “Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer,” Biomarkers, vol. 15, no. 6, pp. 516–522, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Kishi, S. Kopetz, Y. S. Chun, M. Palavecino, E. K. Abdalla, and J.-N. Vauthey, “Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy,” Annals of Surgical Oncology, vol. 16, no. 3, pp. 614–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. G. J. Guthrie, C. S. Roxburgh, O. M. Farhan-Alanie, P. G. Horgan, and D. C. McMillan, “Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer,” British Journal of Cancer, vol. 109, no. 1, pp. 24–28, 2013. View at Publisher · View at Google Scholar
  30. P. Fox, M. Hudson, C. Brown et al., “Markers of systemic inflammation predict survival in patients with advanced renal cell cancer,” British Journal of Cancer, vol. 109, no. 1, pp. 147–153, 2013. View at Publisher · View at Google Scholar
  31. Y. Mano, K. Shirabe, Y. Yamashita et al., “Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis,” Annals of Surgery, vol. 258, no. 2, pp. 301–305, 2013. View at Publisher · View at Google Scholar
  32. A. Demirtaş, V. Sabur, E. C. Akınsal et al., “Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy?” The Scientific World Journal, vol. 2013, Article ID 703579, 5 pages, 2013. View at Publisher · View at Google Scholar
  33. A. M. di Giacomo, L. Calabrò, R. Danielli et al., “Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme,” Cancer Immunology, Immunotherapy, vol. 62, no. 6, pp. 1021–1028, 2013. View at Publisher · View at Google Scholar
  34. J. Szkandera, G. Absenger, B. Liegl-Atzwanger et al., “Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients,” British Journal of Cancer, vol. 108, no. 8, pp. 1677–1683, 2013. View at Publisher · View at Google Scholar
  35. M. Kobayashi, T. Kubo, K. Komatsu et al., “Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy,” Medical Oncology, vol. 30, no. 2, article 556, 2013. View at Publisher · View at Google Scholar
  36. T. Dumitrascu, D. Chirita, M. Ionescu, and I. Popescu, “Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome,” Journal of Gastrointestinal Surgery, vol. 17, no. 5, pp. 913–924, 2013. View at Publisher · View at Google Scholar
  37. Y. Yao, D. Yuan, H. Liu, X. Gu, and Y. Song, “Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy,” Cancer Immunology, Immunotherapy, vol. 62, no. 3, pp. 471–479, 2013. View at Publisher · View at Google Scholar
  38. D. Keizman, M. Gottfried, M. Ish-Shalom et al., “Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram,” The Oncologist, vol. 17, no. 12, pp. 1508–1514, 2012. View at Publisher · View at Google Scholar
  39. M. E. McNally, A. Martinez, H. Khabiri et al., “Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization,” Annals of Surgical Oncology, vol. 20, no. 3, pp. 923–928, 2013. View at Publisher · View at Google Scholar
  40. J. H. Jeong, S. M. Lim, J. Y. Yun et al., “Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer,” Oncology, vol. 83, no. 5, pp. 292–299, 2012. View at Publisher · View at Google Scholar
  41. T. C. Chua, C. H. Chong, W. Liauw, J. Zhao, and D. L. Morris, “Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy,” Annals of Surgery, vol. 256, no. 2, pp. 342–349, 2012. View at Publisher · View at Google Scholar
  42. R. Carruthers, L. M. Tho, J. Brown, S. Kakumanu, E. McCartney, and A. C. McDonald, “Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer,” Colorectal Disease, vol. 14, no. 10, pp. e701–e707, 2012. View at Publisher · View at Google Scholar
  43. D. J. Pinato and R. Sharma, “An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma,” Translational Research, vol. 160, no. 2, pp. 146–152, 2012. View at Publisher · View at Google Scholar
  44. S.-F. Chiang, H.-Y. Hung, R. Tang et al., “Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?” International Journal of Colorectal Disease, vol. 27, no. 10, pp. 1347–1357, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Sato, Y. Tsubosa, and T. Kawano, “Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer,” World Journal of Surgery, vol. 36, no. 3, pp. 617–622, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. T.-M. Chen, C.-C. Lin, P.-T. Huang, and C.-F. Wen, “Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation,” Journal of Gastroenterology and Hepatology, vol. 27, no. 3, pp. 553–561, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Thavaramara, C. Phaloprakarn, S. Tangjitgamol, and S. Manusirivithaya, “Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer,” The Journal of the Medical Association of Thailand, vol. 94, no. 7, pp. 871–877, 2011. View at Google Scholar · View at Scopus
  48. Z.-L. Huang, J. Luo, M.-S. Chen, J.-Q. Li, and M. Shi, “Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization,” Journal of Vascular and Interventional Radiology, vol. 22, no. 5, pp. 702–709, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Chua, K. A. Charles, V. E. Baracos, and S. J. Clarke, “Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer,” British Journal of Cancer, vol. 104, no. 8, pp. 1288–1295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Rashid, N. Waraich, I. Bhatti et al., “A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection,” World Journal of Surgical Oncology, vol. 8, article 1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. K. J. Halazun, M. A. Hardy, A. A. Rana et al., “Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma,” Annals of Surgery, vol. 250, no. 1, pp. 141–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Gomez, G. Morris-Stiff, G. J. Toogood, J. P. A. Lodge, and K. R. Prasad, “Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma,” Journal of Surgical Oncology, vol. 97, no. 6, pp. 513–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Shibutani, K. Maeda, H. Nagahara et al., “A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer,” Anticancer Research, vol. 33, no. 8, pp. 3291–3294, 2013. View at Google Scholar
  54. H. Z. Malik, K. R. Prasad, K. J. Halazun et al., “Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases,” Annals of Surgery, vol. 246, no. 5, pp. 806–814, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Lee, S. H. Kim, J. Y. Han, H. T. Kim, T. Yun, and J. S. Lee, “Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy,” Journal of Cancer Research and Clinical Oncology, vol. 138, no. 12, pp. 2009–2016, 2012. View at Publisher · View at Google Scholar
  56. M. J. Proctor, D. S. Morrison, D. Talwar et al., “An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study,” British Journal of Cancer, vol. 104, no. 4, pp. 726–734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. M. J. Proctor, P. G. Horgan, D. Talwar, C. D. Fletcher, D. S. Morrison, and D. C. McMillan, “Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study,” Cancer, vol. 119, no. 12, pp. 2325–2332, 2013. View at Publisher · View at Google Scholar
  58. L. M. Forrest, D. C. McMillan, C. S. McArdle, W. J. Angerson, and D. J. Dunlop, “Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer,” British Journal of Cancer, vol. 89, no. 6, pp. 1028–1030, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. D. C. McMillan, J. E. M. Crozier, K. Canna, W. J. Angerson, and C. S. McArdle, “Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer,” International Journal of Colorectal Disease, vol. 22, no. 8, pp. 881–886, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Ramadori, J. van Damme, H. Rieder, and K.-H. M. zum Buschenfelde, “Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1β and tumor necrosis factor-α,” European Journal of Immunology, vol. 18, no. 8, pp. 1259–1264, 1988. View at Google Scholar · View at Scopus
  61. E. Sierko and M. Z. Wojtukiewicz, “Platelets and angiogenesis in malignancy,” Seminars in Thrombosis & Hemostasis, vol. 30, no. 1, pp. 95–108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. D. C. McMillan, “The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer,” Cancer Treatment Reviews, vol. 39, no. 5, pp. 534–540, 2013. View at Publisher · View at Google Scholar
  63. N. MacDonald, “Terminology in cancer cachexia: importance and status,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 15, no. 3, pp. 220–225, 2012. View at Publisher · View at Google Scholar
  64. G. J. Guthrie, K. A. Charles, C. S. Roxburgh, P. G. Horgan, D. C. McMillan, and S. J. Clarke, “The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer,” Critical Reviews in Oncology/Hematology, vol. 88, no. 1, pp. 218–230, 2013. View at Publisher · View at Google Scholar
  65. C. Fondevila, J. P. Metges, J. Fuster et al., “p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer,” British Journal of Cancer, vol. 90, no. 1, pp. 206–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Monreal, J. Fernandez-Llamazares, M. Piñol et al., “Platelet count and survival in patients with colorectal cancer—a preliminary study,” Thrombosis and Haemostasis, vol. 79, no. 5, pp. 916–918, 1998. View at Google Scholar · View at Scopus
  67. Y. Takahashi, C. D. Bucana, Y. Akagi et al., “Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer,” Clinical Cancer Research, vol. 4, no. 2, pp. 429–434, 1998. View at Google Scholar · View at Scopus
  68. T. Browder, J. Folkman, and S. Pirie-Shepherd, “The hemostatic system as a regulator of angiogenesis,” The Journal of Biological Chemistry, vol. 275, no. 3, pp. 1521–1524, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Shimada, N. Takiguchi, O. Kainuma et al., “High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer,” Gastric Cancer, vol. 13, no. 3, pp. 170–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Imai, K. Koike, T. Kubo et al., “Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro,” Blood, vol. 78, no. 8, pp. 1969–1974, 1991. View at Google Scholar · View at Scopus
  71. F. W. Ruscetti, “Hematologic effects of interleukin-1 and interleukin-6,” Current Opinion in Hematology, vol. 1, no. 3, pp. 210–215, 1994. View at Google Scholar · View at Scopus
  72. M. Ishizuka, H. Nagata, K. Takagi, Y. Iwasaki, and K. Kubota, “Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer,” Journal of Surgical Oncology, vol. 106, no. 7, pp. 887–891, 2012. View at Publisher · View at Google Scholar
  73. N. P. Symbas, M. F. Townsend, R. El-Galley, T. E. Keane, S. D. Graham, and J. A. Petros, “Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma,” British Journal of Urology International, vol. 86, no. 3, pp. 203–207, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. A. A. Khorana and R. L. Fine, “Pancreatic cancer and thromboembolic disease,” The Lancet Oncology, vol. 5, no. 11, pp. 655–663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. M. L. George, S. A. Eccles, M. G. Tutton, A. M. Abulafi, and R. I. Swift, “Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?” Clinical Cancer Research, vol. 6, no. 8, pp. 3147–3152, 2000. View at Google Scholar · View at Scopus
  76. E. Gunsilius, A. Petzer, G. Stockhammer et al., “Thrombocytes ave the major source for soluble vascular endothelial growth factor in peripheral blood,” Oncology, vol. 58, no. 2, pp. 169–174, 2000. View at Google Scholar · View at Scopus
  77. M. Troxler, K. Dickinson, and S. Homer-Vanniasinkam, “Platelet function and antiplatelet therapy,” British Journal of Surgery, vol. 94, no. 6, pp. 674–682, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Gorelick, V. Andikyan, M. MacK, Y.-C. Lee, and O. Abulafia, “Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population,” International Journal of Gynecological Cancer, vol. 19, no. 8, pp. 1384–1389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. O. Lavie, G. Comerci, V. Daras, B. S. Bolger, A. Lopes, and J. M. Monaghan, “Thrombocytosis in women with vulvar carcinoma,” Gynecologic Oncology, vol. 72, no. 1, pp. 82–86, 1999. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Gislason and E. Nou, “Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study,” European Journal of Respiratory Diseases, vol. 66, no. 2, pp. 141–146, 1985. View at Google Scholar · View at Scopus
  81. H. Shimada, G. Oohira, S.-I. Okazumi et al., “Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma,” Journal of the American College of Surgeons, vol. 198, no. 5, pp. 737–741, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. R. E. Schwarz and H. Keny, “Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma,” Hepato-Gastroenterology, vol. 48, no. 41, pp. 1493–1498, 2001. View at Google Scholar · View at Scopus
  83. K. Suzuki, K. Aiura, M. Kitagou et al., “Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients,” Hepato-Gastroenterology, vol. 51, no. 57, pp. 847–853, 2004. View at Google Scholar · View at Scopus
  84. K. M. Brown, C. Domin, G. V. Aranha, S. Yong, and M. Shoup, “Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas,” The American Journal of Surgery, vol. 189, no. 3, pp. 278–282, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Ishizuka, H. Nagata, K. Takagi, Y. Iwasaki, and K. Kubota, “Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer,” British Journal of Cancer, vol. 109, no. 2, pp. 401–407, 2013. View at Publisher · View at Google Scholar
  86. S. Balta, S. Demirkol, M. Unlu, Z. Arslan, and T. Celik, “Comment on “a derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients”,” British Journal of Cancer, vol. 109, no. 12, pp. 3125–3126, 2013. View at Google Scholar
  87. J. Szkandera, M. Pichler, M. Stotz, and A. Gerger, “Reply: comment on ‘a derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients’,” British Journal of Cancer, vol. 109, no. 12, pp. 3126–3127, 2013. View at Google Scholar
  88. P. Forget and M. de Kock, “Perspectives in anaesthesia for cancer surgery,” Journal of Cancer Research and Clinical Oncology, vol. 140, no. 3, pp. 353–359, 2014. View at Publisher · View at Google Scholar
  89. R. Motaghedi, J. J. Bae, S. G. Memtsoudis et al., “Association of obesity with inflammation and pain after total hip arthroplasty,” Clinical Orthopaedics and Related Research, vol. 472, no. 5, pp. 1442–1448, 2014. View at Publisher · View at Google Scholar
  90. D. Lacombe, S. Burock, and F. Meunier, “Academia-industry partnerships: are we ready for new models of partnership?: the point of view of the EORTC, an academic clinical cancer research organisation,” European Journal of Cancer, vol. 49, no. 1, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  91. P. Forget, B. Tombal, J.-L. Scholtès et al., “Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?” European Journal of Anaesthesiology, vol. 28, no. 12, pp. 830–835, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. J. P. Cata, V. Gottumukkala, and D. I. Sessler, “How regional analgesia might reduce postoperative cancer recurrence,” European Journal of Pain Supplements, vol. 5, no. 2, pp. 345–355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. I. Bhatti, O. Peacock, G. Lloyd, M. Larvin, and R. I. Hall, “Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio,” The American Journal of Surgery, vol. 200, no. 2, pp. 197–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. R. A. Smith, L. Bosonnet, M. Raraty et al., “Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma,” The American Journal of Surgery, vol. 197, no. 4, pp. 466–472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. N. Sakka, R. A. Smith, P. Whelan et al., “A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours,” Pancreatology, vol. 9, no. 5, pp. 670–676, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. R. A. Smith, P. Ghaneh, R. Sutton, M. Raraty, F. Campbell, and J. P. Neoptolemos, “Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio,” Journal of Gastrointestinal Surgery, vol. 12, no. 8, pp. 1422–1428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. R. A. Smith, L. Bosonnet, P. Ghaneh et al., “The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer,” Surgery, vol. 143, no. 5, pp. 658–666, 2008. View at Publisher · View at Google Scholar · View at Scopus